Showing results (211-220 of 501) with videos related to
Sort By:
Pageof 51
Circulation Research|March 1, 1989
Distribution and three-dimensional structure of intercellular junctions in canine myocardiumR H Hoyt, M L Cohen, J E SaffitzThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1983
Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatinM L Cohen, L E Geary, K S WileyHuman Pathology|June 1, 1984
Nodular pulmonary amyloidosis with extrapulmonary involvementS A Laden, M L Cohen, R A HarleyProceedings of the Royal Society of Medicine|January 1, 1977
Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune statusP J Zilko, R L Dawkins, M L CohenGeneral Pharmacology|August 3, 2001
Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob miceM L Cohen, W Bloomquist, D Li, et al.Journal of Cardiovascular Pharmacology|November 1, 1984
Alpha 2-agonist activity of the dopamine DA2-agonist LY171555M L Cohen, C J Shaar, W E ColbertThe Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive ratM L Cohen, R W Fuller, K D KurzScience (New York, N.Y.)|August 24, 1984
Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983S D Holmberg, J G Wells, M L CohenJournal of Clinical Microbiology|October 1, 1988
Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-, and 32-kilodalton antigens of Mycobacterium tuberculosisH S Rumschlag, T M Shinnick, M L CohenClinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHRM L Cohen, K D Kurz, R W FullerPageof 51